02Oct
Financial Daily Dose 10.2.2019 | Top Story: Johnson & Johnson Pays Out $20 Million to Avoid First Opioid Trial
Johnson & Johnson doled out $20 million to two Ohio counties rather than go through with its first federal opioid-related trial. The money is rather small potatoes for J&J, but it marks the “first time . . . the world’s largest maker of healthcare...
By:
Robins Kaplan LLP
Related
Company Fired Seventh-Day Adventist Because She Refused to Work on Her Sabbath, Federal Agency Charg...
Read More >
Employees who transition genders may ask their employer and co-workers to begin addressing them with...
Read More >
The New Jersey Legislature appears poised to pass S67, the Portable Benefits Act for Independent Con...
Read More >
The National Labor Relations Board (“NLRB”) announced that it is releasing a final rule (the “Rul...
Read More >
Cannabis/Marijuana- Bipartisan Coalition of 37 Attorneys General Submits Comment to FDA Regarding C...
Read More >
Generally, a 403(b) plan is a retirement planning program whereby a public school or tax-exempt 501(...
Read More >